Literature DB >> 9423299

[The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis].

K Tsukaguchi1, H Okamura, M Ikuno, A Kobayashi, A Fukuoka, H Takenaka, C Yamamoto, T Tokuyama, Y Okamoto, A Fu, M Yoshikawa, T Yoneda, N Narita.   

Abstract

Diabetics are prone to bacterial infection in part, due to polymorphonuclear neutrophil dysfunction, but the precise mechanism is not yet fully explained. Of many complications, diabetes mellitus (DM) is one of the most common diseases, which causes pulmonary tuberculosis. To elucidate the mechanism of susceptibility to tuberculosis infection in patients with diabetes mellitus, we measured IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and autologous monocytes stimulated with live BCG in patients with pulmonary tuberculosis complicated with DM (TB + DM) or without DM (TB) and healthy controls. The levels of IFN-gamma and IL-12 production in TB patients were significantly lower than those in the control. These cytokine productions were also lower in TB + DM patients than in TB patients significantly. The level of IL-10 production in TB patients were highest among these three groups. The production of this cytokine in TB + DM patients was lowest. The level of IFN-gamma production was significantly lower in TB + DM patients under poor DM control than in those patients under good DM control and showed a significant negative correlation to HbA1c, an indicator of diabetic control. The period for negative conversion of culture finding in TB + DM patients under poor control was prolonged when compared with those in TB patients. These results demonstrated the difference in cytokines secretion profile between TB patients and TB + DM patients, and suggest that the immunological mechanism underlying pathogenesis of tuberculosis might work differently between these two patients groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423299

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  10 in total

1.  Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis.

Authors:  S Yamashiro; K Kawakami; K Uezu; T Kinjo; K Miyagi; K Nakamura; A Saito
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus.

Authors:  J E Stalenhoef; B Alisjahbana; E J Nelwan; J van der Ven-Jongekrijg; T H M Ottenhoff; J W M van der Meer; R H Nelwan; M G Netea; R van Crevel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-26       Impact factor: 3.267

3.  Diabetes mellitus and tuberculosis.

Authors:  Bo Kyung Koo
Journal:  Diabetes Metab J       Date:  2013-08       Impact factor: 5.376

4.  The impact of diabetes on tuberculosis treatment outcomes: a systematic review.

Authors:  Meghan A Baker; Anthony D Harries; Christie Y Jeon; Jessica E Hart; Anil Kapur; Knut Lönnroth; Salah-Eddine Ottmani; Sunali D Goonesekera; Megan B Murray
Journal:  BMC Med       Date:  2011-07-01       Impact factor: 8.775

5.  Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity.

Authors:  Samuel S Stew; Perla J Martinez; Larry S Schlesinger; Blanca I Restrepo
Journal:  Tuberculosis (Edinb)       Date:  2013-12       Impact factor: 2.973

Review 6.  Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Tuberculosis (Edinb)       Date:  2013-12       Impact factor: 2.973

Review 7.  Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis.

Authors:  Rami H Al-Rifai; Fiona Pearson; Julia A Critchley; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

8.  Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.

Authors:  Akhirunnesa Mily; Protim Sarker; Inin Taznin; Delwar Hossain; Md Ahsanul Haq; S M Mostofa Kamal; Birgitta Agerberth; Susanna Brighenti; Rubhana Raqib
Journal:  BMC Infect Dis       Date:  2020-12-07       Impact factor: 3.090

Review 9.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

10.  Forecasting the impact of diabetes mellitus on tuberculosis disease incidence and mortality in India.

Authors:  Susanne F Awad; Peijue Huangfu; Houssein H Ayoub; Fiona Pearson; Soha R Dargham; Julia A Critchley; Laith J Abu-Raddad
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.